Home Blog Page 21

Mesa Royalty Trust (NYSE:MTR) Files An 8-K Results of Operations and Financial Condition

Mesa Royalty Trust (NYSE:MTR) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

On June 18, 2021, Mesa Royalty Trust issued a press release announcing Mesa Royalty Trust’s royalty income and income distribution for the month of June 2021. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

to General Instruction B.2 of Form 8-K and Securities and Exchange Commission Release No. 33-8176, the press release attached as Exhibit 99.1 is not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, is not subject to the liabilities of that section and is not deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, but is instead furnished for purposes of that instruction.

Item 9.01 Financial Statements and Exhibits.

(d)       Exhibits.

99.1 Mesa Royalty Trust Press Release dated June 18, 2021.


MESA ROYALTY TRUST/TX Exhibit
EX-99.1 2 tm2120143d1_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1   Mesa-Royalty-Trust   Mesa Royalty Trust Announces Trust Income for June 2021   MESA ROYALTY TRUST   The Bank of New York Mellon Trust Company,…
To view the full exhibit click here

About Mesa Royalty Trust (NYSE:MTR)

Mesa Royalty Trust owns property interests in the Hugoton Area (Kansas) and the San Juan Basin (Northwestern New Mexico and Southwestern Colorado). The Trust does not engage in any operations. The gas produced from the Hugoton properties is available for sale on the spot market. The natural gas produced from the San Juan Basin is sold on the spot market.

Story continues below

ADVAXIS, INC. (NASDAQ:ADXS) Files An 8-K Submission of Matters to a Vote of Security Holders

ADVAXIS, INC. (NASDAQ:ADXS) Files An 8-K Submission of Matters to a Vote of Security Holders

About ADVAXIS, INC. (NASDAQ:ADXS)

Advaxis, Inc. is a clinical-stage biotechnology company. The Company’s immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm or Listeria) bioengineered to secrete antigen/adjuvant fusion proteins. It is focused on the discovery, development and commercialization of Lm-LLO cancer immunotherapies. The Company’s immunotherapy candidates include Axalimogene filolisbac, ADXS-PSA and ADXS-HER2. Axalimogene filolisbac (ADXS-HPV) is a lead Lm-LLO immunotherapy product candidate for the treatment of human papilloma virus (HPV) associated cancers. ADXS-PSA is an Lm-LLO immunotherapy product candidate designed to target the Prostate Specific Antigen (PSA) associated with prostate cancer. ADXS-HER2 is an Lm-LLO immunotherapy product candidate designed for the treatment of Human Epidermal Growth Factor Receptor 2 (HER2) expressing cancers, including human and canine osteosarcoma, breast, gastric and other cancers.

Story continues below

SHINECO, INC. (NASDAQ:TYHT) Files An 8-K Submission of Matters to a Vote of Security Holders

SHINECO, INC. (NASDAQ:TYHT) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07

At the annual meeting of stockholders of Shineco, Inc. (the “Company”) held on June 15, 2021, the Company’s stockholders voted on the matters described below.

2,598,471 25,451

There were no broker non-votes on the proposal to ratify the selection of the Company’s independent registered public accounting firm for the year ending June 30, 2021.


About SHINECO, INC. (NASDAQ:TYHT)

Shineco, Inc. is a holding company. The Company provides health and well-being focused plant-based products by using its subsidiaries’ and variable interest entities’ vertically- and horizontally-integrated production, distribution and sales channels. The Company operates through three segments: developing, manufacturing and distributing of specialized fabrics, textile products and other by-products derived from an indigenous Chinese plant called Apocynum Venetum, known as Bluish Dogbane (Luobuma); planting, processing and distributing of traditional Chinese medicinal herbal products, as well as other pharmaceutical products (Herbal products), and planting, processing and distributing of green and organic agricultural produce, as well as growing and cultivating of Chinese Yew trees (Agricultural products). It utilizes engineering technologies and biotechnologies to produce, among other products, Chinese herbal medicines, organic agricultural produce and specialized textiles.

Story continues below

HUGOTON ROYALTY TRUST (NYSE:HGT) Files An 8-K Results of Operations and Financial Condition

HUGOTON ROYALTY TRUST (NYSE:HGT) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.

On June 18, 2021, the Registrant issued a news release announcing that it will not declare a monthly cash distribution for the month of June 2021. A copy of the news release is furnished as Exhibit 99.1.

The information in this Current Report, including the news release attached hereto, is being furnished to Item 2.02 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that Section.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit 99.1 News Release dated June 18, 2021

2


HUGOTON ROYALTY TRUST Exhibit
EX-99.1 2 d145156dex991.htm EX-99.1 EX-99.1 EXHIBIT 99.1 [NEWS RELEASE LETTERHEAD OF HUGOTON ROYALTY TRUST APPEARS HERE] HUGOTON ROYALTY TRUST DECLARES NO JUNE CASH DISTRIBUTION Dallas,…
To view the full exhibit click here

About HUGOTON ROYALTY TRUST (NYSE:HGT)

Hugoton Royalty Trust is an express trust. The Company is created pursuant to the Hugoton Royalty Trust Indenture between XTO Energy Inc., as grantor, and NationsBank, N.A., as trustee. Southwest Bank is now the trustee of the trust of the Company. XTO Energy is a subsidiary of Exxon Mobil Corporation. Its properties are gas-producing properties located in the Hugoton area of Oklahoma and Kansas, the Anadarko Basin of Oklahoma and the Green River Basin of Wyoming. XTO Energy operates approximately 95% of the properties. The Company’s Hugoton area is a domestic natural gas producing area. XTO Energy is a producer in the Ringwood, Northwest Okeene and Cheyenne Valley fields of Major County, the Northeast Cedardale field of Woodward County and the Elk City field of Beckham County, the principal producing region of the properties in the Anadarko Basin. The Green River Basin is located in southwestern Wyoming.

Story continues below

Earth Science Tech, Inc. (OTCMKTS:ETST) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Earth Science Tech, Inc. (OTCMKTS:ETST) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Principal Officers

Wendell Hecker has resigned from his position as CFO of Earth Science Tech, Inc. effective June 15, 2021.


About Earth Science Tech, Inc. (OTCMKTS:ETST)

Earth Science Tech, Inc. is a biotechnology company. The Company is focused on nutraceuticals and bioceuticals for use in various industries, such as health, wellness, nutritional supplements, cosmetic and alternative medicine to manage illnesses and the quality of life for consumers around the world. The Company sells its products through its retail store located in Coral Gables, Florida, and through the Internet. The Company is focused on delivering nutritional and dietary supplements that help with treating symptoms, such as chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea and aging. This may include products, such as vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products. These products will be in various formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs.

Story continues below

PULMATRIX, INC. (NASDAQ:PULM) Files An 8-K Submission of Matters to a Vote of Security Holders

PULMATRIX, INC. (NASDAQ:PULM) Files An 8-K Submission of Matters to a Vote of Security Holders

About PULMATRIX, INC. (NASDAQ:PULM)

Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition, the Company focuses on pulmonary diseases through collaboration with partners, including PUR0200, a generic in clinical development for chronic obstructive pulmonary disease.

Story continues below

MERA PHARMACEUTICALS, INC. (OTCMKTS:MRPI) Files An 8-K Entry into a Material Definitive Agreement

MERA PHARMACEUTICALS, INC. (OTCMKTS:MRPI) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01

On June 10, 2021, the Company entered into an agreement with Revive through its wholly owned subsidiary All Your Foods USA, Inc. bringing business currently revenueing into the corporation. Revive provides healthy and delicious premium pre-portioned frozen Superfoods smoothies, oats, meals and more delivered right to the customers door. Revive currently delivers over a million smoothies a month. The Company is Revives food Production and development partner.

All your foods has officially become the main food production company outside of Revives production for new and soon existing products.

This two year deal will see AYF and Revive develop new products and improve on existing ones.

9.01 Exhibits

99.1         Revive Agreement


MERA PHARMACEUTICALS INC Exhibit
EX-99 2 e2851_ex99-1.htm EX-99     Exhibit 99.1   Manufacturing and Supply Agreement   On June 11,…
To view the full exhibit click here

About MERA PHARMACEUTICALS, INC. (OTCMKTS:MRPI)

Mera Pharmaceuticals, Inc. is a marine biotechnology company. The Company focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The Company manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The Company also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The Company offers nigari in sizes ranging from one gallon to 250 gallons.

Story continues below

BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Results of Operations and Financial Condition

BIOTRICITY INC. (OTCMKTS:BTCY) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition

On June 15, 2021, Biotricity, Inc. (the “Company”) issued a press release reporting certain unaudited financial results for the 2021 fourth quarter and fiscal year ended March 31, 2021 and gave certain guidance. The full text of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

to General Instruction B.2. to Form 8-K, the information set forth in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall any of them be incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.

    

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. The exhibit listed in the following Exhibit Index is furnished as part of this Current Report on Form 8-K:


BIOTRICITY INC. Exhibit
EX-99.1 2 ex99-1.htm   Exhibit 99.1   Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021   REDWOOD CITY,…
To view the full exhibit click here

About BIOTRICITY INC. (OTCMKTS:BTCY)

Biotricity Inc is a Canada-based medical technology company. The Company delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It offers bioflux, an Electrocardiogram (ECG) monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects arrhythmias, performs remote mobile cardiac telemetry diagnostic monitoring, and transmits ECG data via a built-in cellular radio in real time. The Company also provides biolife, a health and lifestyle solution for individuals, which consists of a device that monitors heart-rhythm or ECG, as well as respiration, calories, temperature, physical activity, and other.

Story continues below

Monroe Capital Corporation (NASDAQ:MRCC) Files An 8-K Submission of Matters to a Vote of Security Holders

Monroe Capital Corporation (NASDAQ:MRCC) Files An 8-K Submission of Matters to a Vote of Security Holders

About Monroe Capital Corporation (NASDAQ:MRCC)

Monroe Capital Corporation is a closed-end, non-diversified management investment company. The Company is a specialty finance company focused on providing financing primarily to lower middle-market companies in the United States. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation primarily through investments in senior, unitranche and junior secured debt, and unsecured subordinated debt and equity. The Company provides customized financing solutions focused primarily on senior secured, junior secured and unitranche (a combination of senior secured and junior secured debt in the same facility) debt, and subordinated debt and equity, including equity co-investments in preferred and common stock and warrants. The Company’s investment activities are managed by its investment advisor, Monroe Capital BDC Advisors, LLC (MC Advisors).

Story continues below

GOLDRICH MINING COMPANY (OTCMKTS:GRMC) Files An 8-K Regulation FD Disclosure

GOLDRICH MINING COMPANY (OTCMKTS:GRMC) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.  

 

On June 11, 2021, the Registrant issued the attached news release entitled “Goldrich Mining Releases Initial Assessment Report”, wherein the Company reported the results of the independent Initial Assessment Report (the “IA”) for the Company’s Chandalar Mine in the Chandalar Gold District in Alaska. The IA was prepared by Global Resources Engineering (“GRE”), a widely-respected mining engineering firm in Denver, Colorado.

Highlights – At $1,650 Base Case Gold Price:

·After-tax Net Present Value (NPV) (5%) of $64 million and Internal Rate of Return (IRR) of 139%  

·$25 million in Undiscounted After-tax Net Cash Flow (NCF) generated by year two and $72 million generated in total. 

·All-in sustaining costs of $799 per ounce of gold (Au) 

·After-tax payback period of 1.3 years after start of commercial production 

·Initial mine life of 7 years with significant potential to extend lifespan 

·Project also includes extensive additional upside with higher gold price and resource growth potential   

Due to new amendments recently adopted by the SEC to modernize property disclosure requirements for mining registrants, the preparation of the IA allows Goldrich to disclose Measured, Indicated, and Inferred resources for the first time.

Key Economic Results

Key Economic Results of the IA with a summarized gold price sensitivity analysis are as follows:

(1) Tax calculation includes use of a GRMC $39 million tax loss carryforward.

The IA uses a base case gold price of $1,650/oz, which is the 24-month trailing average gold price as required by the new SEC regulations. The base case shows robust economics with an after-tax undiscounted net cash flow of $72 million, an IRR of 139%, and a Payback Period of 1.3 years. At recent gold prices of around $1,900/oz, the sensitivity analysis shows an undiscounted after-tax cash flow of $95 million, an IRR of 180%, and a Payback Period of 1.2 years.

 

Mineral Resource Estimate

Pit-constrained Mineral Resource Estimate for the Little Squaw Creek Placer Deposit:

(1) Raw Gold – Gold as recovered from the placer deposit, historically 84% gold and 16% other metals like silver and copper (referred to as 840 fine).

(2) Fine Gold – Gold that is 99.99% pure (referred to as 9999 fine).

The Chandalar Mine resource database includes the results from 395 drill holes, totaling 35,930 feet from three previous drilling campaigns (2007: 104 holes totaling 15,400 feet; 2013: 61 holes totaling 6,300 feet; and, 2017: 230 holes totaling 14,300 feet). The Mineral Resource estimate is based on a gold cutoff grade of 0.002 raw troy ounces (840 fineness) per bank cubic yard (bcy) at an assumed gold price of 1,600 $/tr oz, assumed mining cost of $4.50/bcy, assumed processing and administrative cost of $7.25/bcy, an assumed metallurgical recovery of 84%, and pit slopes of 45 degrees.

 

To determine the accuracy of the block model used for the resource estimation, GRE completed various studies, including a production reconciliation to the block model. The reconciliation compared the reported raw ounces produced from 2009 through 2018 with the estimated raw ounces using the consolidated mined-out surface for the same time period as summarized in the table below:

The block model estimated 47,700 raw ounces (at an assumed cutoff grade of 0.002 ounces per yard [opy]) compared to actual production of 53,900 raw ounces, which was 12% greater than the estimate. If actual future production continues to be greater than the block model estimate as it has in the past, this would further strengthen the project’s already highly profitable projected economics.

Capital and Operating Cost

Estimated capital costs total $25.6 million, including initial capital of $15.1 million. Capital costs for the project include mining production and support equipment leases that assume 25% down payment of the purchase price and a lease term varying from 20 to 26 quarters, depending on the piece of equipment and when it is needed on the project at 5% interest. They also include a heavy equipment shop and fuel station, process equipment, camp, and site development.

 

The estimated operating costs total $95.2 million over 7 years, with a cash operating cost of $646/fine Au oz and an all-in sustaining cost of $799/fine Au oz. Operating cash costs are based on a surface mine plan, haul cycle analysis, drill and blast cost analysis, with delivery to the remote mining site by either air (landing strip already available at the mine site) or by a winter ice road. Remote labor rates and burdens were used that are consistent with other remote mining operations in the arctic region of Alaska. Power costs for the camp and wash plants is based on generated power using diesel fuel.

Preliminary Economic Assessment

GRE has also prepared a Preliminary Economic Assessment (PEA) according to Canadian 43-101 standards, which is similar to the U.S. IA, but the PEA will not be released unless Goldrich lists on a Canadian stock exchange.

Item 9.01Financial Statements and Exhibits. 

(d)Exhibits 

Exhibit No.Description 

96.1Initial Assessment Chandalar Mine 

99.1News Release, June 11, 202 

* Furnished to, not filed with, the SEC to Item 7.01 above.


GOLDRICH MINING CO Exhibit
EX-96.1 2 report_ex96z1.htm EXHIBIT 96.1 Exhibit 96.1     Date and Signature Page This Technical Report on the Chandalar Project is submitted to Goldrich Mining Company and is effective May 31,…
To view the full exhibit click here

About GOLDRICH MINING COMPANY (OTCMKTS:GRMC)

Goldrich Mining Company is an exploration-stage minerals company. The Company is engaged in the business of acquiring and advancing mineral properties to the discovery points. The Company’s mineral exploration prospects are contained within its Chandalar property, located approximately 190 air miles north of Fairbanks, Alaska and over 40 air miles east of the Dalton Highway. The Chandalar property contains both the Company’s Chandalar hard-rock (lode) gold project and the Little Squaw Creek alluvial gold mine. The Company has completed approximately 15,000 feet of drilling on the upper half of the Little Squaw Creek placer project and outlined over 10.5 million cubic yards of mineralized material, at an average head grade of over 0.025 ounces of gold per cubic yard for an estimated total of approximately 250,000 contained ounces. The Company’s Chandalar property is approximately 22,860 acres, consisting of patented federal mining claims and unpatented State of Alaska mining claims.

Story continues below